How Does Philly PEP? Who gets HIV Post Exposure Prophylaxis & Who are we missing?

Thursday, September 23rd 2021

2:00 PM

Register Now
Registration Required

Post Exposure Prophylaxis (PEP), the provision of antiretroviral therapy within 72 hours of a high-risk exposure is a highly effective HIV prevention tool. PEP is a critical piece or the Ending the HIV Epidemic (EHE) initiative, as it helps reduce the transmission or HIV
following exposure, and provides an opportunity for linkage to low-barrier care and risk reduction and HIV prevention tools, such as Pre-Exposure Prophylaxis (PrEP). This
webinar will discuss epidemiologic data on PEP in Philadelphia, and real-world successes and challenges, with an eye towards improving PEP delivery services in Philadelphia.



Helen C. Koenig, MD, MPH

Philadelphia FIGHT/UPENN


Anna Thomas-Ferraioli

Philadelphia Health Department

Location Details


Spotlight On

Karam Mounzer, MD

Dr. Mounzer identified two major gaps in the care of patients with HIV/hepatitis C (HCV) co-infection, and the complexity of multidrug-resistant HIV treatment. He is involved with many clinical trials focusing on drug development and better understanding of HIV immunopathogenesis with the Wistar Institute. He is involved in teaching and mentoring.

Learn More about Spotlight On
Dr. Karam Mounzer

Dr. Mario Cruz

Dr. Mario CruzDr. Cruz is a board certified pediatrician who serves as the Medical Director for our Pediatrics and Adolescent Health Center. He has presented and/or published in the fields of community violence and domestic violence prevention, quality improvement, behavioral health, curriculum development and mentorship. In 2019 he received the Greater Philadelphia Social Innovation Award for Innovations in Healthcare.

Translate »